Table 1.
Antibiotic resistance profiles of ATCC strains used in the study (S: susceptibility; R: resistant bacterial strain).
| Antibiotic Resistance Profile of the ATCC Bacterial Strains | ||
|---|---|---|
| Antibiotics | MIC (mg/L) | Interpretation |
| S. aureus ATCC 6538 | ||
| Fusidic acid | ≤0.5 | S |
| Daptomycin | 0.25 | S |
| Erythromycin | ≤0.25 | S |
| Fosfomycin | ≤8 | S |
| Gentamicin | ≤0.5 | S |
| Linezolid | 2 | S |
| Levofloxacin | ≤0.12 | S |
| Oxacillin | ≤0.25 | S |
| Teicoplanin | ≤0.5 | S |
| Tetracycline | ≤1 | S |
| Tigecycline | ≤0.12 | S |
| Trimethoprim/sulfamethoxazole | ≤10 | S |
| Vancomycin | 0.5 | S |
| Penicillin | ≤0.03 | S |
| Rifampicin | ≤0.03 | S |
| E. faecalis ATCC 29212 | ||
| Ampicillin | 2 | S |
| Gentamicin/syn | 500 | S |
| Imipenem | 1 | S |
| Linezolid | 2 | S |
| Teicoplanin | 0.5 | S |
| Tigecycline | 0.12 | S |
| Vancomycin | 2 | S |
| Cefuroxime | 64 | R |
| E. coli ATCC 11229 | ||
| Amikacin | 2 | S |
| Amoxicillin/clavulanate | 2 | S |
| Ampicillin | 8 | S |
| Cefepime | 1 | S |
| Cefotaxime | 1 | S |
| Ceftazidime | 1 | S |
| Cefuroxime | 4 | S |
| Ciprofloxacin | 0.25 | S |
| Ertapenem | 0.5 | S |
| Fosfomycin | 16 | S |
| Gentamicin | 1 | S |
| Imipenem | 0.25 | S |
| Levofloxacin | 0.5 | S |
| Meropenem | 0.25 | S |
| Piperacillin | 8 | S |
| Piperacillin/tazobactam | 4 | S |
| Tobramycin | 1 | S |
| Trimethoprim/sulfamethoxazole | 20 | S |
| Tigecycline | 0.5 | S |
| K. pneumoniae ATCC 10031 | ||
| Ciprofloxacin | 0.25 | S |
| Fosfomycin | 16 | S |
| Ampicillin | 8 | S |
| Gentamicin | 1 | S |
| Trimethoprim/sulfamethoxazole | 20 | S |
| Amikacin | 2 | S |
| Amoxicillin/clavulanate | 2 | S |
| Cefepime | 1 | S |
| Cefotaxime | 1 | S |
| Cefotaxime | 1 | S |
| Ertapenem | 0.5 | S |
| Imipenem | 0.5 | S |
| Meropenem | 0.25 | S |
| Piperacillin/tazobactam | 4 | S |
| Colistin | 0.5 | S |